Earnings Feed
Start Free
BIOMARIN PHARMACEUTICAL INC·4

Jun 26, 8:23 PM ET

BAFFI ROBERT 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Jun 26, 2018

Insider Transaction Report

Form 4
Period: 2018-06-22
BIOMARIN PHARMACEUTICAL INCBMRN
BAFFI ROBERT
SVP, Technial Operations
Transactions
  • Sale

    Common Stock

    2018-06-22$99.00/sh−6,621$655,479→ 83,604 total
  • Exercise/Conversion

    Stock Option (Right to buy Common Stock)

    2018-06-22−6,949→ 0 total
    Exercise: $14.39From: 2009-11-12Exp: 2019-05-11→ Common Stock (6,949 underlying)
  • Sale

    Common Stock

    2018-06-22$99.01/sh−328$32,475→ 83,276 total
  • Exercise/Conversion

    Common Stock

    2018-06-22$14.39/sh+6,949$99,996→ 90,225 total
Holdings

  • Common Stock

    (indirect: By Trust)
    77,055
Footnotes (2)
  • [F1]Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.
  • [F2]Reflects the number of options outstanding after the transactions from this specific stock option grant.

Documents

2 files